Tuberculosis and its future in the COVID-19 era: The Pulmonology series 2021

Migliori, Giovanni Battista; Tiberi, Simon; García‐Basteiro, Alberto L.; Duarte, Raquel

doi:10.1016/j.pulmoe.2020.10.005

Cited by 11 publications

(13 citation statements)

References 16 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…An increased use of telehealth during the COVID-19 pandemic was observed in some TB centres [11]. The major limitations of that study were the short period of observation (January-April 2020 compared to the same period in 2019) and the limited number of variables analysed [11][12][13][14].…”

Section: Dear Editormentioning

confidence: 99%

See 1 more Smart Citation

Gauging the impact of the COVID-19 pandemic on tuberculosis services: a global study

et al. 2021

Self Cite

View full text Add to dashboard Cite

Section: Dear Editormentioning

confidence: 99%

“…Given the advanced health systems in these countries, this is likely due to enhanced surveillance to both TB and COVID-19 [12,14,15]. A reduction of identified TB disease cases was observed even in low TB incidence countries (e.g., Italy, France, and Spain), which were considerably affected by the COVID-19 pandemic.…”

Section: Dear Editormentioning

confidence: 99%

Gauging the impact of the COVID-19 pandemic on tuberculosis services: a global study

et al. 2021

Self Cite

View full text Add to dashboard Cite

“…In total, 3.5% of new TB cases and 18% of patients with a history of previous treatment were found to be MDR-TB. 6 This makes the MDR strain become a prime global concern. WHO has been targeting an end TB strategy based on an assessment of the TB epidemic and progress in TB diagnosis, treatment, and prevention efforts.…”

Section: Introductionmentioning

confidence: 99%

The Magnitude of MTB and Rifampicin Resistance MTB Using Xpert-MTB/RIF Assay Among Tuberculosis Suspected Patients in Gedeo Zone, Southern Ethiopia

Diriba¹,

Awulachew²,

Churiso³

2021

IDR

View full text Add to dashboard Cite

Background Tuberculosis (TB) remains a major global health problem causing death among millions of people each year. The new barrier that challenges the control of tuberculosis is the emerging and the increasing number of drug-resistant TB that becomes a world concern. This study aimed to determine the magnitude of rifampicin-resistant Mycobacterium tuberculosis (RR-MTB) among presumptive TB patients attending Dilla University Referral Hospital, Gedeo Zone, Ethiopia. Methods A retrospective cross-sectional study was conducted at Dilla University Referral Hospital from January 2014 to December 2020. Sputum results were done using Xpert MTB/RIF assay and other necessary data were collected from the registration logbooks using a standardized data extraction format and analyzed using SPSS version 23 statistical software. Results A total of 17,745 presumptive TB patients were included, of which 62.2% were males. The overall prevalence of Mycobacterium tuberculosis (MTB) was 11.8%, of which 5.1% were confirmed to have RR-MTB. Extra-pulmonary TB was reported in 1.5% of the study participants. The highest prevalence of MTB and RR-MTB was recorded in 2017 with a prevalence of 20.1% and 8.5%, respectively. All age groups were significantly associated with a higher prevalence of MTB ( p < 0.036). TB patients with a history of previous treatment and HIV positive were significantly associated with MTB ( P < 0.021), while RR-MTB was only significantly associated with patients with a history of previous treatment ( P < 0.018). Conclusion A high magnitude of MTB and RR-MTB was reported among TB patients with HIV and a history of previous treatment. Therefore, coordinated efforts should be applied to the improvement of treatment adherence of known TB cases, and appropriate control and prevention methods to reduce the emergence and increase of MTB and RR-MTB cases.

show abstract

“…Involvement of almost every organ has been described in extrapulmonary TB infection (EPTB), including lymphatic, pleural, bone and joint, genitourinary, and meningeal sites. TBP is the sixth most common site of EPTB, accounting for 4.9% of all EPTB cases [3,4]. TB may reach the peritoneum hematogenously through the lymphatic system by the ingestion of contaminated sputum from pulmonary TB, contaminated food (especially unpasteurized dairy in the case of Mycobacterium bovis), or through direct extension from adjacent foci of infection [8,9].…”

Section: Discussionmentioning

confidence: 99%

“…TB is a chronic granulomatous infectious disease caused by Mycobacterium tuberculosis and commonly affects the respiratory system. For these reasons, lung disease is the most common TB presentation, but other manifestations are also possible depending on the duration and location of the disease [3]. Peritoneal TB (TBP) is rare, accounting for about 1-2% of all TB cases.…”

Section: Introductionmentioning

confidence: 99%

Peritoneal Tuberculosis Mimicking Ovarian Cancer: Gynecologic Ultrasound Evaluation with Histopathological Confirmation

Arezzo

Cazzato

Loizzi

et al. 2021

Gastroenterology Insights

View full text Add to dashboard Cite

Peritoneal tuberculosis (TBP) is a very rare condition, accounting for about 1–2% of all tuberculosis cases. The diagnosis of TBP can be easily mistaken for advanced ovarian cancer (AOC) or peritoneal carcinoma because of overlapping laboratory and clinical findings. We reported the ultrasound characteristics of a case of TBP in a 67-year-old woman who presented to our institute with a 1-month history of intermittent lower abdominal pain, fever, and asthenia. Overall, 20 biopsy-retrieved specimen histopathological features were suggestive of peritoneal tuberculosis. Gynecologic ultrasound revealed increased adnexa with multiple nodular formations spread across the surface, suggestive of caseous nodules. Although this is a rare occurrence, clinicians should consider TBP as a differential diagnosis of ovarian or peritoneal cancer.

show abstract

Tuberculosis and its future in the COVID-19 era: The Pulmonology series 2021

Cited by 11 publications

References 16 publications

Gauging the impact of the COVID-19 pandemic on tuberculosis services: a global study

Gauging the impact of the COVID-19 pandemic on tuberculosis services: a global study

The Magnitude of MTB and Rifampicin Resistance MTB Using Xpert-MTB/RIF Assay Among Tuberculosis Suspected Patients in Gedeo Zone, Southern Ethiopia

Peritoneal Tuberculosis Mimicking Ovarian Cancer: Gynecologic Ultrasound Evaluation with Histopathological Confirmation

Contact Info

Product

Resources

About